PMA device
G-Armor Stent
NuMED, Inc. · Aortic Stent (PNF, Class III) · First FDA decision Dec 13, 2021, newest Dec 13, 2021Congenital heart disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
0
Naming "G-Armor"
MAUDE reports
3
Brand "G-Armor", since 2015
PubMed studies
2
Mentioning "G-Armor"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing G-Armor Stent
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- G-Armor Stent, G-Armor Covered Stent, G-Armor Mounted Stent, G-Armor Covered Mounted StentPMA supplement
P150028-S006 · Decided Dec 13, 2021 · 90 days after receipt · Normal 180 Day Track
Device type: Aortic stent (PNF) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "G-Armor", any status and sponsor, newest update first.
No registered device study names "G-Armor".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "G-Armor", and for the whole product code for context.
This brand
3 reports: 3 malfunction, 0 injury, 0 death
Whole product code PNF
92 reports: 73 malfunction, 18 injury, 1 death
Newest reports for this brand
- G-ARMOR COVERED MOUNTED STENTMalfunction
1318694-2025-00003 · Received Jun 2, 2025 · Event dated May 3, 2025
Device type: Aortic Stent (PNF)
Device problem as coded: Difficult to Insert
Patient problem as coded: Insufficient Information
- G-ARMOR COVERED STENTMalfunction
1318694-2023-00001 · Received Jan 17, 2023 · Event dated Dec 14, 2022
Device type: Aortic Stent (PNF)
Device problem as coded: Improper or Incorrect Procedure or Method
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- 10 ZIG 8.4 CM G-ARMOR STENTMalfunction
16121246 · Received Jan 9, 2023 · Event dated Dec 14, 2022
Device type: Aortic Stent (PNF)
Device problem as coded: Device Dislodged or Dislocated
Patient problem as coded: Foreign Body In Patient
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "G-Armor"[tiab]. The summary above synthesizes these.
- Customized Pulmonary Artery Stent for Management of Complex Coronary Artery Fistula.
Amir R, Thomson J, Cedars A, et al. · JACC Case Rep · 2025Case Reports
- Concomitant Discovery and Treatment of Acquired and Congenital Cardiac Disease.
Bartra S, Khalili H, Forbes TJ, et al. · JACC Case Rep · 2026Case Reports
Other devices of this type
Also filed under product code PNF.
- Minima Stent SystemRenata Medical, Inc. · PMA 2026
- Cheatham Platinum (CP) Stent System (Covered CP StentNuMED, Inc. · PMA 2017
- Minima Pro Stent SystemRenata Medical, Inc. · PMA 2026
- CP Stent (Model 425)NuMED, Inc. · PMA 2026
- NuDel Delivery SystemNuMED, Inc. · PMA 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.